Zaragoza, October 14 (EUROPE PRESS) –
Starting this Monday, October 14, people over 85 will be able to get vaccinated against flu and Covid-19 by booking an appointment at their health center. This Monday also marks the start of a campaign for hospital medical staff.
In addition, on October 1 last year, vaccination began in nursing homes, among medical and socio-medical staff of primary health care, as well as among pregnant women who make an appointment with their nurse.
The campaign will continue on Monday, October 21, for children aged 6 to 59 months, for whom self-registration will be open from October 17, with a pilot plan starting in 29 schools throughout Aragon.
In the latter case, children of the first and second grades of preschool education, that is, children under 3 and 4 years old from these 29 schools, will be vaccinated. On October 28, vaccination will begin in the age group from 65 to 84 years old by self-registration, which will be available from October 24; and Nov. 11 for ages 60 to 64 and at-risk groups, with open appointments available starting Nov. 7.
The main purpose of this immunization is to protect people who are more likely to have complications due to age or previous conditions.
TARGET POPULATION GROUPS FOR VACCINATION AGAINST FLU AND COVID
Because of the greater risk of complications or serious conditions from these infections, vaccination is recommended for people aged 60 years and older, people 5 years and older, residents of disability centers and nursing homes, and other people in institutions. long-term treatment and stay in closed institutions. Also people under the age of 60 with risk conditions such as diabetes mellitus, morbid obesity, chronic cardiovascular, neurological or respiratory diseases, including bronchopulmonary dysplasia, cystic fibrosis, immunosuppression and others.
In addition, pregnant women in any trimester of gestation and women in the postpartum period – up to 6 months after birth and not vaccinated during pregnancy – and people living with people who have a high degree of immunosuppression.
Cohabitants of people with other higher-risk conditions and older conditions may also be included.
In order to reduce exposure and maintain critical and essential services to the community, staff of public and private health and social care centers are strongly encouraged to get vaccinated – both in health care and other areas, with the exception of students, for whom vaccination is only recommended. . against the flu…
Likewise, for people who work in essential government services, with particular emphasis on the following subgroups: Government security forces and agencies with national, regional or local dependencies. Firefighters. Civil protection services.
TARGET POPULATIONS FOR FLU VACCINATION
The flu vaccination campaign generally targets the same groups as last year: people aged 5 to 59, who are at higher risk of complications from the flu. This group includes people aged 5-18 years receiving long-term treatment with acetylsalicylic acid, due to the possibility of developing Reye’s syndrome after influenza.
Also smokers, students undergoing internships in medical and socio-medical centers, people who have direct occupational exposure to animals or their excretions on farms or poultry, pig or mink farms or wild fauna – birds, wild boars or mustelids – and the children’s population. aged 6-59 months.
Children under 2 years old will be given an intramuscular injection, and from two years old – intranasally.
also in relation to the staff of kindergartens and preschool education centers – children under the age of 5 years.
RESPIRATORY SYNCYCYL VIRUS This immunization is recommended for all children born between April 1, 2024, and March 31, 2025, and will be administered as follows: Children under 6 months of age born between April 1, 2024, and March 31, 2025. March, In 2025 they will be vaccinated at their medical center.
For babies born after October 1 and throughout the season, they will receive a dose at the maternity hospital.
As for children with risk factors, they will also receive a dose in the hospital. This group includes premature infants less than 35 weeks of age, before reaching 12 months of chronological age, a pediatric population at high risk of severe RSV disease, including some congenital heart defects. bronchopulmonary dysplasia or those who have undergone heart surgery using artificial circulation.
This group also includes children with other pathologies that pose a high risk of developing severe bronchiolitis, such as: immunosuppression, inborn errors of metabolism, neuromuscular diseases, diseases. severe pulmonary diseases, genetic syndromes with associated respiratory problems, Down syndrome, cystic fibrosis and children in palliative care.